Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2009 Nov 10;77(4):1120–1127. doi: 10.1016/j.ijrobp.2009.06.067

Table 5.

Characteristics of the 8 disease-free failure patients

Case Age Stage Tumor size
(cm)
Node+ ER+ Menopausal
status
Tumor
location
Margins Chemo Tam Failure type
A 67 I 0.7 No Yes Postmenopausal LIQ Neg No No INF (axilla) DF
B 73 I 1.7 Yes Yes Surgical menopause UOQ Neg No Yes DF Death (spine metastases)
C 50 I 0.3 No Yes Postmenopausal UC Neg Yes, after XRT No IBF (outside field) Simple mastectomy
D 80 I 1.3 No Yes Postmenopausal UIQ Neg No Yes INF (axilla) Bilateral mastectomy
E 84 I 0.7 No NR Postmenopausal UOQ Neg No No IBF (within field, invasive) IBF (skin of treated breast) INF* (axilla), DF Death (liver metastases)
F 70 I 1.4 No Yes Postmenopausal LOQ Neg No No Death (bladder, second primary)
G 60 I 1.2 No NR Surgical menopause UOQ Initially Pos No No IBF (within field, invasive) Bilateral mastectomy
H 53 I 0.6 Yes NR Postmenopausal UOQ Neg Yes, prior to XRT No DF

Abbreviations: IBF = ipsilateral breast failure; chemo = chemotherapy; ER = estrogen receptor status; DF = distant failure; INF = ipsilateral nodal failure; LOQ = lower inner quadrant; NR = not reported; tam = tamoxifen; UC = upper central; UIQ = upper inner quadrant; UOQ = upper outer quadrant; XRT = radiation therapy.

*

This failure met the protocol-specified criteria for INF.

202 days from surgery to radiation therapy.